January 2018 FDA Recall Ampicillin And Sulbactam by Aurobindo Pharma Ltd.
D-0339-2018 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Aurobindo Pharma Ltd. on January 2, 2018 for the product Ampicillin And Sulbactam. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0339-2018

Reason for Recall
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
Initiated
01-02-2018
Reported
02-14-2018
Quantity
53,040 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Aurobindo Pharma Ltd.
distributed nationwide in the USA
Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20

Batch or Lot Expiration Information

Lot# Lot Number AF0117001-A